FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TARLOXOTINIB BROMIDE
异名/同义词(2E)-4-((4-(3-BROMO-4-CHLOROANILINO)PYRIDO(3,4-D)PYRIMIDIN-6-YL)AMINO)-N,N-DIMETHYL-N-((1-METHYL-4-NITRO-1H-IMIDAZOL-5-YL)METHYL)-4-OXOBUT-2-EN-1-AMINIUM BROMIDE
1H-IMIDAZOLE-5-METHANAMINIUM, N-((2E)-4-((4-((3-BROMO-4-CHLOROPHENYL)AMINO)PYRIDO(3,4-D)PYRIMIDIN-6-YL)AMINO)-4-OXO-2-BUTEN-1-YL)-N,N,1-TRIMETHYL-4-NITRO-, BROMIDE (1:1)
TARLOXOTINIB BROMIDE
TARLOXOTINIB BROMIDE [INN]
TARLOXOTINIB BROMIDE [WHO-DD]
CAS登记号1636180-98-7
物质唯一标识(Unique Ingredient Identifier)3Y31FJ8K50
分子式C24H24BrClN9O3.Br
国际化合物标识(International Chemical Identifier,InChI)WAKIMVYUBWMMHJ-FXRZFVDSSA-N
SMILES[Br-].c1(cc2c(cn1)ncnc2Nc3ccc(c(c3)Br)Cl)NC(/C=C/C[N+](C)(C)Cc4n(cnc4[N+]([O-])=O)C)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System